{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T16:24:04Z","timestamp":1761841444312,"version":"build-2065373602"},"reference-count":211,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.ecl.2011.08.003","type":"journal-article","created":{"date-parts":[[2011,11,22]],"date-time":"2011-11-22T05:55:08Z","timestamp":1321941308000},"page":"865-894","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Achieving a Successful Pregnancy in Women with Polycystic Ovary Syndrome"],"prefix":"10.1016","volume":"40","author":[{"given":"Takako","family":"Araki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rony","family":"Elias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zev","family":"Rosenwaks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonid","family":"Poretsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ecl.2011.08.003_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhea associated with bilateral polycystic ovaries","volume":"29","author":"Stein","year":"1935","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ecl.2011.08.003_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2011.08.003_bib3","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib4","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/humupd\/dmm026","article-title":"The role of metformin in polycystic ovary syndrome: a systematic review","volume":"13","author":"Moll","year":"2007","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ecl.2011.08.003_bib6","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2011.08.003_bib7","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib8","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2011.08.003_bib9","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1055\/s-2008-1042958","article-title":"Oocyte quality in adult polycystic ovary syndrome","volume":"26","author":"Patel","year":"2008","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.ecl.2011.08.003_bib10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/humupd\/dmg024","article-title":"Obesity and reproductive disorders in women","volume":"9","author":"Pasquali","year":"2003","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ecl.2011.08.003_bib11","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/sj.ijo.0800424","article-title":"Women\u2019s reproductive health: the role of body mass index in early and adult life","volume":"21","author":"Lake","year":"1997","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.ecl.2011.08.003_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-9378(94)90465-0","article-title":"Adolescent body mass index and infertility caused by ovulatory disorder","volume":"171","author":"Rich-Edwards","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ecl.2011.08.003_bib13","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.ecl.2011.08.003_bib14","doi-asserted-by":"crossref","first-page":"33S","DOI":"10.1016\/S0002-9343(99)80057-6","article-title":"Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus","volume":"98","author":"Dunaif","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.ecl.2011.08.003_bib15","first-page":"97","article-title":"Polycystic ovary syndrome. Long term sequelae and management","volume":"54","author":"Legro","year":"2002","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.ecl.2011.08.003_bib16","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.2337\/diacare.24.6.1050","article-title":"Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes","volume":"24","author":"Peppard","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ecl.2011.08.003_bib17","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.1210\/jc.2005-0469","article-title":"Direct thiazolidinedione action in the human ovary: insulin-independent and insulin-sensitizing effects on steroidogenesis and insulin-like growth factor binding protein-1 production","volume":"90","author":"Seto-Young","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib18","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1210\/jcem-61-4-728","article-title":"Distribution and characterization of insulin and insulin-like growth factor I receptors in normal human ovary","volume":"61","author":"Poretsky","year":"1985","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/edrv.20.4.0374","article-title":"The insulin-related ovarian regulatory system in health and disease","volume":"20","author":"Poretsky","year":"1999","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2011.08.003_bib20","series-title":"Principles of diabetes mellitus","first-page":"701","article-title":"Polycystic ovary syndrome","author":"Poretsky","year":"2010"},{"key":"10.1016\/j.ecl.2011.08.003_bib21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.fertnstert.2003.08.012","article-title":"Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin","volume":"81","author":"Maciel","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2011.08.003_bib22","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0960-0760(93)90249-V","article-title":"Regulation of the aromatase activity of human placental cytotrophoblasts by insulin, insulin-like growth factor-I, and -II","volume":"44","author":"Nestler","year":"1993","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.ecl.2011.08.003_bib23","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.1210\/en.2003-0457","article-title":"Gonadotropin-releasing hormone secretion from hypothalamic neurons: stimulation by insulin and potentiation by leptin","volume":"144","author":"Burcelin","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.ecl.2011.08.003_bib24","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0026-0495(92)90175-A","article-title":"Hyperinsulinemia and human chorionic gonadotropin synergistically promote the growth of ovarian follicular cysts in rats","volume":"41","author":"Poretsky","year":"1992","journal-title":"Metabolism"},{"key":"10.1016\/j.ecl.2011.08.003_bib25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000160911","article-title":"Insulin modulation of luteinizing hormone secretion in normal female volunteers and lean polycystic ovary syndrome patients","volume":"89","author":"Moret","year":"2009","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ecl.2011.08.003_bib26","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.brainres.2010.08.088","article-title":"Evidence that obesity and androgens have independent and opposing effects on gonadotropin production from puberty to maturity","volume":"1364","author":"Rosenfield","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.ecl.2011.08.003_bib27","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1210\/jc.2006-2274","article-title":"Pulsatile luteinizing hormone amplitude and progesterone metabolite excretion are reduced in obese women","volume":"92","author":"Jain","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib28","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1210\/edrv-8-2-132","article-title":"The gonadotropic function of insulin","volume":"8","author":"Poretsky","year":"1987","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2011.08.003_bib29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1055\/s-2007-1016298","article-title":"Can polycystic ovary syndrome exist without concomitant hypothalamic dysfunction?","volume":"15","author":"Berga","year":"1997","journal-title":"Semin Reprod Endocrinol"},{"key":"10.1016\/j.ecl.2011.08.003_bib30","first-page":"895","article-title":"Increased luteinizing hormone and alpha-subunit secretion in women with hyperandrogenic anovulation","volume":"77","author":"Berga","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib31","first-page":"2854","article-title":"Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features","volume":"81","author":"Morales","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2265.1988.tb01208.x","article-title":"Episodic pulsatile secretion of FSH, LH, prolactin, oestradiol, oestrone, and LH circadian variations in polycystic ovary syndrome","volume":"28","author":"Venturoli","year":"1988","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2011.08.003_bib33","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1056\/NEJM198903023200904","article-title":"Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome","volume":"320","author":"Barnes","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2011.08.003_bib34","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/oxfordjournals.humrep.a137638","article-title":"Granulosa cells of polycystic ovaries: are they normal or abnormal?","volume":"7","author":"Erickson","year":"1992","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2011.08.003_bib35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-2265.1997.2321049.x","article-title":"Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome","volume":"47","author":"Gilling-Smith","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2011.08.003_bib36","first-page":"4103","volume":"81","author":"Ibanez","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib37","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1093\/humrep\/12.9.1890","article-title":"Further evidence of increased aromatase activity in granulosa luteal cells from polycystic ovary","volume":"12","author":"Pierro","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2011.08.003_bib38","first-page":"1599","article-title":"Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism","volume":"76","author":"Ibanez","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib39","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0015-0282(97)81396-9","article-title":"Girls diagnosed with premature pubarche show an exaggerated ovarian androgen synthesis from the early stages of puberty: evidence from gonadotropin-releasing hormone agonist testing","volume":"67","author":"Ibanez","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2011.08.003_bib40","first-page":"614","article-title":"Decreased insulin sensitivity in prepubertal girls with premature adrenarche and acanthosis nigricans","volume":"80","author":"Oppenheimer","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib41","first-page":"613","article-title":"Insulin resistance, hypersecretion of LH, and a dual-defect hypothesis for the pathogenesis of polycystic ovary syndrome","volume":"84","author":"Poretsky","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ecl.2011.08.003_bib42","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/humupd\/dmi013","article-title":"Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?","volume":"11","author":"Abbott","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ecl.2011.08.003_bib43","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S1043-2760(02)00689-6","article-title":"Fetal programming of coronary heart disease","volume":"13","author":"Barker","year":"2002","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib44","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0889-8529(18)30409-2","article-title":"Familial polycystic ovarian disease","volume":"17","author":"Givens","year":"1988","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ecl.2011.08.003_bib45","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2265.1988.tb03707.x","article-title":"Familial polycystic ovaries: a genetic disease?","volume":"29","author":"Hague","year":"1988","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2011.08.003_bib46","doi-asserted-by":"crossref","first-page":"14956","DOI":"10.1073\/pnas.95.25.14956","article-title":"Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome","volume":"95","author":"Legro","year":"1998","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.ecl.2011.08.003_bib47","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1210\/jc.2006-2123","article-title":"Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis","volume":"92","author":"Wood","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib48","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/0002-9378(95)91488-9","article-title":"Chronic hyperinsulinemia and the adrenal androgen response to acute corticotropin-(1\u201324) stimulation in hyperandrogenic women","volume":"172","author":"Azziz","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ecl.2011.08.003_bib49","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1210\/jcem-22-3-325","article-title":"The polycystic ovary. I. Clinical and histologic features","volume":"22","author":"Goldzieher","year":"1962","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib50","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/09513598709023610","article-title":"Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies","volume":"1","author":"Hull","year":"1987","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ecl.2011.08.003_bib51","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","journal-title":"BMC Med"},{"year":"1991","series-title":"Reproductive endocrinology","author":"Yen","key":"10.1016\/j.ecl.2011.08.003_bib52"},{"key":"10.1016\/j.ecl.2011.08.003_bib53","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/humrep\/13.6.1502","article-title":"Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment","volume":"13","author":"Clark","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2011.08.003_bib54","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/oxfordjournals.humrep.a019512","article-title":"Effects of weight loss on the hormonal profile in obese, infertile women","volume":"11","author":"Hollmann","year":"1996","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2011.08.003_bib55","first-page":"1470","article-title":"Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone","volume":"84","author":"Huber-Buchholz","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib56","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S1472-6483(10)61182-0","article-title":"Effects of lifestyle modification in polycystic ovarian syndrome","volume":"12","author":"Moran","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ecl.2011.08.003_bib57","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2265.1992.tb02909.x","article-title":"Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome","volume":"36","author":"Kiddy","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2011.08.003_bib58","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1477-7827-1-109","article-title":"The management of infertility associated with polycystic ovary syndrome","volume":"1","author":"Homburg","year":"2003","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.ecl.2011.08.003_bib59","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2265.1993.tb02378.x","article-title":"Response of sex hormone binding globulin and insulin-like growth factor binding protein-1 to an oral glucose tolerance test in obese women with polycystic ovary syndrome before and after calorie restriction","volume":"39","author":"Hamilton-Fairley","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2011.08.003_bib60","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/oxfordjournals.bmb.a011617","article-title":"Obesity and female reproductive function","volume":"53","author":"Pettigrew","year":"1997","journal-title":"Br Med Bull"},{"key":"10.1016\/j.ecl.2011.08.003_bib61","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/oxfordjournals.humrep.a135772","article-title":"Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women","volume":"10","author":"Clark","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2011.08.003_bib62","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.fertnstert.2004.02.104","article-title":"A\u00a0randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and\/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study","volume":"82","author":"Hoeger","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2011.08.003_bib63","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1055\/s-2003-41177","article-title":"Adherence and attrition with intermittent and continuous exercise in overweight women","volume":"24","author":"Jacobsen","year":"2003","journal-title":"Int J Sports Med"},{"key":"10.1016\/j.ecl.2011.08.003_bib64","first-page":"1401","volume":"87","author":"Greenblatt","year":"1965","journal-title":"Concours Med"},{"key":"10.1016\/j.ecl.2011.08.003_bib65","first-page":"425","article-title":"Polycystic ovary syndrome and ovulation induction","volume":"55","author":"Yildiz","year":"2003","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.ecl.2011.08.003_bib66","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.fertnstert.2007.12.002","article-title":"Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction, achievement of pregnancy, and live birth in Asian women with polycystic ovary syndrome: a randomized controlled trial","volume":"91","author":"Zain","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2011.08.003_bib67","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00006250-197803000-00002","article-title":"Ovulation and pregnancy rates with clomiphene citrate","volume":"51","author":"Gorlitsky","year":"1978","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ecl.2011.08.003_bib68","first-page":"2361","article-title":"Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility","volume":"83","author":"Imani","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib69","first-page":"1617","article-title":"Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility","volume":"84","author":"Imani","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib70","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/humrep\/dem426","article-title":"Consensus on infertility treatment related to polycystic ovary syndrome","volume":"23","author":"Thessaloniki ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2008","journal-title":"Hum Reprod"},{"year":"2005","series-title":"Clinical gynecologic endocrinology and infertility","author":"Speroff","key":"10.1016\/j.ecl.2011.08.003_bib71"},{"key":"10.1016\/j.ecl.2011.08.003_bib72","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0015-0282(01)02963-6","article-title":"Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome","volume":"77","author":"Nestler","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2011.08.003_bib73","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0015-0282(16)57597-9","article-title":"Clomiphene citrate reduces serum insulin-like growth factor I and increases sex hormone-binding globulin levels in women with polycystic ovary syndrome","volume":"63","author":"Butzow","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2011.08.003_bib74","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1056\/NEJM199806253382603","article-title":"Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome","volume":"338","author":"Nestler","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2011.08.003_bib75","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/oxfordjournals.humrep.a137165","article-title":"Sonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth","volume":"5","author":"Gonen","year":"1990","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2011.08.003_bib76","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1093\/humrep\/13.8.2110","article-title":"Sequential clomiphene citrate and human menopausal gonadotrophin with intrauterine insemination: the effect of patient age on clinical outcome","volume":"13","author":"Brzechffa","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2011.08.003_bib77","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0015-0282(16)44711-4","article-title":"The use of human gonadotropins for the induction of ovulation in women with polycystic ovarian disease","volume":"33","author":"Wang","year":"1980","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2011.08.003_bib78","first-page":"3821","article-title":"Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women","volume":"81","author":"White","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib79","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/humrep\/deg336","article-title":"A\u00a0comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome","volume":"18","author":"Christin-Maitre","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2011.08.003_bib80","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0015-0282(99)00208-3","article-title":"Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome","volume":"72","author":"De Leo","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2011.08.003_bib81","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/humrep\/17.2.289","article-title":"Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: a prospective randomized trial","volume":"17","author":"Yarali","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2011.08.003_bib82","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1471-0528.1985.tb01111.x","article-title":"Successful treatment of infertile women with oligomenorrhoea using a combination of an LHRH agonist and exogenous gonadotrophins","volume":"92","author":"Fleming","year":"1985","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ecl.2011.08.003_bib83","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/humrep\/16.4.644","article-title":"Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation","volume":"16","author":"European and Middle East Orgalutran Study Group","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2011.08.003_bib84","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.fertnstert.2004.06.076","article-title":"A\u00a0randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist\/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist\/rFSH in women pretreated with oral contraceptives before in\u00a0vitro fertilization","volume":"83","author":"Barmat","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2011.08.003_bib85","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome","volume":"356","author":"Legro","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2011.08.003_bib86","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0026-0495(94)90209-7","article-title":"Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy","volume":"43","author":"Velazquez","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.ecl.2011.08.003_bib87","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/humrep\/16.8.1625","article-title":"Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries: a randomized, double-blinded placebo-controlled trial","volume":"16","author":"Ng","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2011.08.003_bib88","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1210\/me.2009-0474","article-title":"AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation","volume":"24","author":"Ning","year":"2010","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ecl.2011.08.003_bib89","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJM199608293350902","article-title":"Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome","volume":"335","author":"Nestler","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2011.08.003_bib90","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(00)01766-0","article-title":"Metformin treatment of patients with polycystic ovary syndrome undergoing in\u00a0vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors","volume":"75","author":"Stadtmauer","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2011.08.003_bib91","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1210\/jc.2005-0110","article-title":"Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome","volume":"90","author":"Palomba","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib92","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.fertnstert.2006.05.069","article-title":"Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction and achievement of pregnancy in 154 women with polycystic ovary syndrome","volume":"87","author":"Neveu","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2011.08.003_bib93","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1136\/bmj.38867.631551.55","article-title":"Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial","volume":"332","author":"Moll","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.ecl.2011.08.003_bib94","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/AOG.0b013e31816a4ed4","article-title":"Use of metformin in polycystic ovary syndrome: a metaanalysis","volume":"111","author":"Creanga","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ecl.2011.08.003_bib95","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0015-0282(01)02929-6","article-title":"A\u00a0nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility","volume":"77","author":"Imani","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2011.08.003_bib96","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1210\/jc.2009-0545","article-title":"Predictors of pregnancy in women with polycystic ovary syndrome","volume":"94","author":"Rausch","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib97","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nrendo.2009.251","article-title":"Reproductive endocrinology: live birth prediction in polycystic ovary syndrome","volume":"6","author":"Nader","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ecl.2011.08.003_bib98","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF01221950","article-title":"Metformin in management of pregnant insulin-independent diabetics","volume":"16","author":"Coetzee","year":"1979","journal-title":"Diabetologia"},{"key":"10.1016\/j.ecl.2011.08.003_bib99","first-page":"3299","article-title":"The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome","volume":"81","author":"Dunaif","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib100","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1093\/humrep\/14.11.2700","article-title":"High ovulatory rates with use of troglitazone in clomiphene-resistant women with polycystic ovary syndrome","volume":"14","author":"Mitwally","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2011.08.003_bib101","first-page":"1626","article-title":"Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial","volume":"86","author":"Azziz","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib102","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.fertnstert.2003.08.024","article-title":"Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome","volume":"81","author":"Belli","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2011.08.003_bib103","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/humrep\/deg343","article-title":"Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin","volume":"18","author":"Glueck","year":"2003","journal-title":"Hum Reprod"},{"issue":"14","key":"10.1016\/j.ecl.2011.08.003_bib104","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1001\/archinternmed.2010.207","article-title":"Rosiglitazone revisited: an updated metaanalysis of risk for myocardial infarction and cardiovascular mortality","volume":"170","author":"Nissen","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ecl.2011.08.003_bib105","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1210\/endo.142.11.8429","article-title":"Expression and localization of PPARs in the rat ovary during follicular development and the periovulatory period","volume":"142","author":"Komar","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.ecl.2011.08.003_bib106","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1210\/jc.2006-1935","article-title":"Interactions among peroxisome proliferator activated receptor-gamma, insulin signaling pathways, and steroidogenic acute regulatory protein in human ovarian cells","volume":"92","author":"Seto-Young","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib107","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1067\/mob.2001.111242","article-title":"Troglitazone is a competitive inhibitor of 3beta-hydroxysteroid dehydrogenase enzyme in the ovary","volume":"184","author":"Gasic","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ecl.2011.08.003_bib108","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1006\/bbrc.2000.2701","article-title":"Insulin sensitizer, troglitazone, directly inhibits aromatase activity in human ovarian granulosa cells","volume":"271","author":"Mu","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ecl.2011.08.003_bib109","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.2337\/diacare.28.5.1092","article-title":"Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes","volume":"28","author":"DeFronzo","year":"2005","journal-title":"Diabetes Care"},{"issue":"Pt 3","key":"10.1016\/j.ecl.2011.08.003_bib110","first-page":"190","article-title":"The entero-insular axis in polycystic ovarian syndrome","volume":"33","author":"Gama","year":"1996","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.ecl.2011.08.003_bib111","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1530\/EJE-08-0097","article-title":"Incretin levels in polycystic ovary syndrome","volume":"159","author":"Vrbikova","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2011.08.003_bib112","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2337\/diabetes.50.3.609","article-title":"Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients","volume":"50","author":"Vilsboll","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ecl.2011.08.003_bib113","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1210\/endo.141.2.7326","article-title":"Neuroendocrine function and response to stress in mice with complete disruption of glucagon-like peptide-1 receptor signaling","volume":"141","author":"MacLusky","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.ecl.2011.08.003_bib114","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2362.2005.01542.x","article-title":"Glucagon-like peptide-1 reduces the pulsatile component of testosterone secretion in healthy males","volume":"35","author":"Jeibmann","year":"2005","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ecl.2011.08.003_bib115","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1210\/jc.2008-0115","article-title":"Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome","volume":"93","author":"Elkind-Hirsch","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib116","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0015-0282(00)01705-2","article-title":"Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate","volume":"75","author":"Mitwally","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2011.08.003_bib117","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/j.fertnstert.2008.11.029","article-title":"Genetic analysis of human embryos by metaphase comparative genomic hybridization (mCGH) improves efficiency of IVF by increasing embryo implantation rate and reducing multiple pregnancies and spontaneous miscarriages","volume":"92","author":"Sher","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2011.08.003_bib118","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.fertnstert.2007.08.034","article-title":"Clomiphene citrate or anastrozole for ovulation induction in women with polycystic ovary syndrome? A prospective controlled trial","volume":"92","author":"Badawy","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2011.08.003_bib119","unstructured":"Health Canada endorsed important safety information on Femara (letrozole) [letter]. 2005. Available at: http:\/\/www.hc-sc.gc.ca\/dhp-mps\/medeff\/advisories-avis\/public\/_2005\/femara_pc-cp-eng.php. Accessed August 2, 2011."},{"key":"10.1016\/j.ecl.2011.08.003_bib120","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0015-0282(16)47896-9","article-title":"A\u00a0randomized study of dexamethasone in ovulation induction with clomiphene citrate","volume":"41","author":"Daly","year":"1984","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2011.08.003_bib121","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0015-0282(16)47234-1","article-title":"Induction of ovulation with combined human gonadotropins and dexamethasone in women with polycystic ovarian disease","volume":"40","author":"Evron","year":"1983","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2011.08.003_bib122","first-page":"497","article-title":"Clomiphene and dexamethasone in women unresponsive to clomiphene alone","volume":"60","author":"Lobo","year":"1982","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ecl.2011.08.003_bib123","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/oxfordjournals.humrep.a019454","article-title":"The addition of a glucocorticoid to the protocol of programmed oocyte retrieval for in-vitro fertilization\u2013a randomized study","volume":"11","author":"Bider","year":"1996","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2011.08.003_bib124","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/HUMREP\/11.2.253","article-title":"Dexamethasone during ovulation induction for in-vitro fertilization: a pilot study","volume":"11","author":"Rein","year":"1996","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2011.08.003_bib125","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0015-0282(99)00146-6","article-title":"Effect of age on the response of the hypothalamo-pituitary-ovarian axis to a combined oral contraceptive","volume":"71","author":"Fitzgerald","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2011.08.003_bib126","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1210\/jc.2007-2437","article-title":"Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline","volume":"93","author":"Martin","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib127","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1210\/jc.2007-2430","article-title":"Clinical review: antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials","volume":"93","author":"Swiglo","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib128","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1345\/aph.1D461","article-title":"Relative safety and efficacy of finasteride for treatment of hirsutism","volume":"38","author":"Townsend","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ecl.2011.08.003_bib129","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0015-0282(16)53214-2","article-title":"Laparoscopic ovarian diathermy in the management of anovulatory infertility in women with polycystic ovaries: endocrine changes and clinical outcome","volume":"53","author":"Armar","year":"1990","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2011.08.003_bib130","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/S0015-0282(16)54737-2","article-title":"Evaluation of adhesion formation after laparoscopic treatment of polycystic ovarian disease","volume":"56","author":"Gurgan","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2011.08.003_bib131","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1093\/humrep\/dei164","article-title":"Individualized cost-effective conventional ovulation induction treatment in normogonadotrophic anovulatory infertility (WHO group 2)","volume":"20","author":"Eijkemans","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2011.08.003_bib132","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1093\/humrep\/12.11.2359","article-title":"Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients","volume":"12","author":"Damario","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2011.08.003_bib133","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/humrep\/dep436","article-title":"Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT)","volume":"25","author":"Lainas","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2011.08.003_bib134","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1472-6483(10)61728-2","article-title":"IVF outcome in anovulatory infertility (WHO group 2)\u2013including polycystic ovary syndrome\u2013following previous unsuccessful ovulation induction","volume":"7","author":"Mulders","year":"2003","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ecl.2011.08.003_bib135","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/humrep\/12.3.474","article-title":"The chromosomal normality of unfertilized oocytes from patients with polycystic ovarian syndrome","volume":"12","author":"Sengoku","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2011.08.003_bib136","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1093\/oxfordjournals.humrep.a136217","article-title":"High incidence of embryo transfer cancellations in patients with polycystic ovarian syndrome","volume":"10","author":"Kodama","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2011.08.003_bib137","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10815-007-9127-8","article-title":"Application of GnRH antagonist in combination with clomiphene citrate and hMG for patients with exaggerated ovarian response in previous IVF\/ICSI cycles","volume":"24","author":"Lin","year":"2007","journal-title":"J\u00a0Assist Reprod Genet"},{"key":"10.1016\/j.ecl.2011.08.003_bib138","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/humupd\/dmi036","article-title":"A\u00a0metaanalysis of outcomes of conventional IVF in women with polycystic ovary syndrome","volume":"12","author":"Heijnen","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ecl.2011.08.003_bib139","first-page":"834","volume":"87","author":"Kdous","year":"2009","journal-title":"Tunis Med"},{"key":"10.1016\/j.ecl.2011.08.003_bib140","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.fertnstert.2007.02.002","volume":"89","author":"Engmann","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2011.08.003_bib141","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S1472-6483(10)60652-9","article-title":"GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a metaanalysis","volume":"13","author":"Griesinger","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ecl.2011.08.003_bib142","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006105.pub2","article-title":"Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome","volume":"2","author":"Tso","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ecl.2011.08.003_bib143","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/oxfordjournals.humrep.a137313","article-title":"In-vitro fertilization in infertile women with the polycystic ovarian syndrome","volume":"6","author":"Dale","year":"1991","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2011.08.003_bib144","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1210\/jcem-71-4-918","article-title":"Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in\u00a0vitro fertilization","volume":"71","author":"Gonen","year":"1990","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib145","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/humrep\/15.1.165","article-title":"Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome","volume":"15","author":"Chian","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2011.08.003_bib146","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1472-6483(10)61101-7","article-title":"In-vitro maturation of immature oocytes for infertile women with PCOS","volume":"8","author":"Chian","year":"2004","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ecl.2011.08.003_bib147","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/humrep\/deg335","article-title":"Combination of FSH priming and hCG priming for in-vitro maturation of human oocytes","volume":"18","author":"Lin","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2011.08.003_bib148","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006606.pub2","article-title":"In\u00a0vitro maturation in sub fertile women with polycystic ovarian syndrome undergoing assisted reproduction","volume":"1","author":"Siristatidis","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ecl.2011.08.003_bib149","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/bmj.297.6655.1024","article-title":"Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome","volume":"297","author":"Homburg","year":"1988","journal-title":"BMJ"},{"key":"10.1016\/j.ecl.2011.08.003_bib150","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1210\/jcem.87.2.8207","article-title":"Effects of metformin on early pregnancy loss in the polycystic ovary syndrome","volume":"87","author":"Jakubowicz","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib151","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1136\/bmj.297.6655.1027","article-title":"Recurrent early miscarriage and polycystic ovaries","volume":"297","author":"Sagle","year":"1988","journal-title":"BMJ"},{"key":"10.1016\/j.ecl.2011.08.003_bib152","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1034\/j.1600-0412.2000.079001043.x","article-title":"Obesity is a risk factor for early pregnancy loss after IVF or ICSI","volume":"79","author":"Fedorcsak","year":"2000","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ecl.2011.08.003_bib153","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0015-0282(97)00486-X","article-title":"The plasminogen activator system in women with polycystic ovary syndrome","volume":"69","author":"Atiomo","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2011.08.003_bib154","first-page":"1126","article-title":"Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome","volume":"86","author":"Jakubowicz","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib155","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1136\/bmj.312.7045.1508","article-title":"Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial","volume":"312","author":"Clifford","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.ecl.2011.08.003_bib156","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0015-0282(00)01666-6","article-title":"Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study","volume":"75","author":"Glueck","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2011.08.003_bib157","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1210\/jcem.83.4.4707","article-title":"High prevalence of polycystic ovaries and associated clinical, endocrine, and metabolic features in women with previous gestational diabetes mellitus","volume":"83","author":"Holte","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib158","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/humrep\/16.2.226","article-title":"Obstetric outcome in women with polycystic ovarian syndrome","volume":"16","author":"Mikola","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2011.08.003_bib159","first-page":"194","article-title":"Impaired glucose tolerance in pregnant women with polycystic ovary syndrome","volume":"94","author":"Radon","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ecl.2011.08.003_bib160","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/humrep\/deg289","article-title":"Pregnancy outcome in women with PCOS and in controls matched by age and weight","volume":"18","author":"Haakova","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2011.08.003_bib161","first-page":"501","article-title":"Pregnancy in infertile PCOD patients. Complications and outcome","volume":"42","author":"Urman","year":"1997","journal-title":"J\u00a0Reprod Med"},{"key":"10.1016\/j.ecl.2011.08.003_bib162","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dml036","article-title":"A\u00a0metaanalysis of pregnancy outcomes in women with polycystic ovary syndrome","volume":"12","author":"Boomsma","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ecl.2011.08.003_bib163","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.fertnstert.2008.06.045","article-title":"Risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and a metaanalysis","volume":"92","author":"Toulis","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2011.08.003_bib164","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ypmed.2009.07.001","article-title":"Gestational diabetes mellitus: all Asians are not alike","volume":"49","author":"Chu","year":"2009","journal-title":"Prev Med"},{"key":"10.1016\/j.ecl.2011.08.003_bib165","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0015-0282(01)03202-2","article-title":"Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome","volume":"77","author":"Glueck","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2011.08.003_bib166","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1447-0756.2008.00856.x","article-title":"Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome?","volume":"34","author":"Nawaz","year":"2008","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.ecl.2011.08.003_bib167","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1210\/jc.2003-030241","article-title":"Insulin resistance and its potential role in pregnancy-induced hypertension","volume":"88","author":"Seely","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib168","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","article-title":"Pre-eclampsia","volume":"376","author":"Steegers","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2011.08.003_bib169","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0028-2243(82)90097-1","article-title":"High incidence of preeclamptic toxemia in patients with polycystic ovarian disease","volume":"14","author":"Diamant","year":"1982","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ecl.2011.08.003_bib170","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1471-0528.1989.tb03288.x","article-title":"The course and outcome of pregnancy after ovarian electrocautery in women with polycystic ovarian syndrome: the influence of body-weight","volume":"96","author":"Gjonnaess","year":"1989","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ecl.2011.08.003_bib171","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0301-2115(97)00164-4","article-title":"Higher risk of preeclampsia in the polycystic ovary syndrome. A case control study","volume":"76","author":"de Vries","year":"1998","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ecl.2011.08.003_bib172","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0020-7292(96)02759-2","article-title":"Hyperinsulinemia increases the risk of gestational hypertension","volume":"55","author":"Hamasaki","year":"1996","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ecl.2011.08.003_bib173","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2337\/diab.30.3.219","article-title":"Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man","volume":"30","author":"Rowe","year":"1981","journal-title":"Diabetes"},{"key":"10.1016\/j.ecl.2011.08.003_bib174","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/10641959909009612","article-title":"Are women with polycystic ovary syndrome at an increased risk of pregnancy-induced hypertension and\/or preeclampsia?","volume":"18","author":"Fridstrom","year":"1999","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ecl.2011.08.003_bib175","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/bmb\/60.1.5","article-title":"The thrifty phenotype hypothesis","volume":"60","author":"Hales","year":"2001","journal-title":"Br Med Bull"},{"issue":"Suppl 2","key":"10.1016\/j.ecl.2011.08.003_bib176","first-page":"B142","article-title":"Long-term effects of the intrauterine environment. The Northwestern University Diabetes in Pregnancy Center","volume":"21","author":"Silverman","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ecl.2011.08.003_bib177","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1210\/jc.2009-1849","article-title":"Associations of birthweight and gestational age with reproductive and metabolic phenotypes in women with polycystic ovarian syndrome and their first-degree relatives","volume":"95","author":"Legro","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib178","doi-asserted-by":"crossref","first-page":"E801","DOI":"10.1152\/ajpendo.00107.2005","article-title":"Postnatal developmental consequences of altered insulin sensitivity in female sheep treated prenatally with testosterone","volume":"289","author":"Recabarren","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib179","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/humrep\/del395","article-title":"Polycystic ovaries after precocious pubarche: relation to prenatal growth","volume":"22","author":"Ibanez","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2011.08.003_bib180","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1542\/peds.2005-0664","article-title":"Early puberty-menarche after precocious pubarche: relation to prenatal growth","volume":"117","author":"Ibanez","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.ecl.2011.08.003_bib181","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1093\/humrep\/dei009","article-title":"Birth weight in offspring of mothers with polycystic ovarian syndrome","volume":"20","author":"Sir-Petermann","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2011.08.003_bib182","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/humupd\/7.1.3","article-title":"Polycystic ovarian disease: heritability and heterogeneity","volume":"7","author":"Crosignani","year":"2001","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ecl.2011.08.003_bib183","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0015-0282(00)01662-9","article-title":"Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS","volume":"75","author":"Kahsar-Miller","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2011.08.003_bib184","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1210\/jc.2008-2836","article-title":"Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome","volume":"94","author":"Sir-Petermann","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib185","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1210\/jc.2007-2256","article-title":"Metabolic profile in sons of women with polycystic ovary syndrome","volume":"93","author":"Recabarren","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib186","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1210\/jc.2007-1036","article-title":"Early metabolic derangements in daughters of women with polycystic ovary syndrome","volume":"92","author":"Sir-Petermann","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib187","first-page":"1206","article-title":"Timing of prenatal androgen excess determines differential impairment in insulin secretion and action in adult female rhesus monkeys","volume":"85","author":"Eisner","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib188","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/oby.2003.42","article-title":"Increased adiposity in female rhesus monkeys exposed to androgen excess during early gestation","volume":"11","author":"Eisner","year":"2003","journal-title":"Obes Res"},{"key":"10.1016\/j.ecl.2011.08.003_bib189","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1210\/jc.2004-0918","article-title":"Insulin resistance and impaired insulin secretion in prenatally androgenized male rhesus monkeys","volume":"89","author":"Bruns","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib190","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0015-0282(16)58687-7","article-title":"Hyperinsulinemia is common in family members of women with polycystic ovary syndrome","volume":"66","author":"Norman","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2011.08.003_bib191","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.96.15.8573","article-title":"Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin","volume":"96","author":"Urbanek","year":"1999","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.ecl.2011.08.003_bib192","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1210\/jcem.86.1.7274","article-title":"Evidence for association of polycystic ovary syndrome in Caucasian women with a marker at the insulin receptor gene locus","volume":"86","author":"Tucci","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib193","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1210\/jc.2002-020216","article-title":"Relationship of insulin receptor substrate-1 and -2 genotypes to phenotypic features of polycystic ovary syndrome","volume":"87","author":"Ehrmann","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib194","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1210\/jcem.87.4.8385","article-title":"Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome","volume":"87","author":"Ehrmann","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib195","doi-asserted-by":"crossref","first-page":"5529","DOI":"10.1210\/jc.2003-030322","article-title":"Specific CAPN10 gene haplotypes influence the clinical profile of polycystic ovary patients","volume":"88","author":"Gonzalez","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib196","first-page":"772","article-title":"Insulin resistance is attenuated in women with polycystic ovary syndrome with the Pro(12)Ala polymorphism in the PPARgamma gene","volume":"87","author":"Hara","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib197","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1080\/09513590600733357","article-title":"Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome","volume":"22","author":"Yilmaz","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ecl.2011.08.003_bib198","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1210\/jc.2009-2703","article-title":"Family-based analysis of candidate genes for polycystic ovary syndrome","volume":"95","author":"Ewens","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib199","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2009.05.012","article-title":"The role of the endogenous opioid system in polycystic ovary syndrome","volume":"92","author":"Eyvazzadeh","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2011.08.003_bib200","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1210\/jcem.87.1.8137","article-title":"The androgen receptor CAG repeat polymorphism and X-chromosome inactivation in Australian Caucasian women with infertility related to polycystic ovary syndrome","volume":"87","author":"Hickey","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib201","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/humrep\/den065","article-title":"Small glutamine-rich tetratricopeptide repeat-containing protein alpha (SGTA), a candidate gene for polycystic ovary syndrome","volume":"23","author":"Goodarzi","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2011.08.003_bib202","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0015-0282(98)00512-3","article-title":"Polymorphism T-->C (-34 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndrome","volume":"71","author":"Diamanti-Kandarakis","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2011.08.003_bib203","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1210\/jc.2003-031640","article-title":"Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone","volume":"89","author":"Gaasenbeek","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib204","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/6.3.397","article-title":"Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism","volume":"6","author":"Gharani","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ecl.2011.08.003_bib205","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1210\/jc.2002-021553","article-title":"Influence of SHBG gene pentanucleotide TAAAA repeat and D327N polymorphism on serum sex hormone-binding globulin concentration in hirsute women","volume":"89","author":"Cousin","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib206","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1210\/jc.2003-030197","article-title":"Association of the (TAAAA)n repeat polymorphism in the sex hormone-binding globulin (SHBG) gene with polycystic ovary syndrome and relation to SHBG serum levels","volume":"88","author":"Xita","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib207","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1093\/humrep\/den324","article-title":"FEM1A and FEM1B: novel candidate genes for polycystic ovary syndrome","volume":"23","author":"Goodarzi","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2011.08.003_bib208","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/09513590500431458","article-title":"FEM1A is a candidate gene for polycystic ovary syndrome","volume":"21","author":"Maher","year":"2005","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ecl.2011.08.003_bib209","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/molehr\/gap072","article-title":"Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries","volume":"15","author":"Prodoehl","year":"2009","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.ecl.2011.08.003_bib210","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1210\/jc.2007-0761","article-title":"Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype","volume":"92","author":"Urbanek","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.08.003_bib211","doi-asserted-by":"crossref","first-page":"6623","DOI":"10.1210\/jc.2005-0622","article-title":"Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2","volume":"90","author":"Urbanek","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852911000685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852911000685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:35:50Z","timestamp":1760175350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852911000685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":211,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0889852911000685"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2011.08.003","relation":{},"ISSN":["0889-8529"],"issn-type":[{"type":"print","value":"0889-8529"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Achieving a Successful Pregnancy in Women with Polycystic Ovary Syndrome","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2011.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}